RSVpreF (Abrysvo) and Nirsevimab-alip (Beyfortus) for the Prevention of Respiratory Syncytial Virus Infection

• 2024

  Log in to bookmark this resource.

  Log in
• Matthew Nodelman; A. Miles Scott
PMID: 38905561

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article provides an overview of the RSVpreF vaccine and nirsevimab-alip for the prevention of severe lower respiratory tract infections from respiratory syncytial virus (RSV). RSVpreF is a vaccine for respiratory syncytial virus (RSV), approved for individuals aged 60 and above and for pregnant women to protect infants from severe lower respiratory tract infections. Nirsevimab-alip is a monoclonal antibody for infants in their first RSV season and children up to 24 months old at risk of severe RSV disease in their second season.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Antiviral Agents; Infant; Pregnant Women; Respiratory Syncytial Virus Infections; Viral Vaccines; Palivizumab; Respiratory Syncytial Virus Vaccines; Vulnerable Populations; Antibodies, Monoclonal, Humanized

Institutions: University of South Carolina

---

More like this

RSVpreF (Abrysvo) and Nirsevimab-alip (Beyfortus) for the Prevention of Respiratory Syncytial Virus Infection 2024 · University of South Carolina The 2021 Toolkit for Emergency Preparedness and Mitigation to Combat Surge of Pediatric COVID-19 Patients in India: The World Health Organization Collaborating Center for Emergency and Trauma in South East Asia Recommendations 2021 · Florida State University, University of Nevada, Las Vegas, Manipal Academy of Higher Education, State University of New York Downstate Health Sciences University Fall 2023 ACIP Update on Meningococcal, RSV, COVID-19, and Other Pediatric Vaccines 2024 · Children's National Hospital, University of South Florida, University of Alabama at Birmingham, University of Colorado, University of Cincinnati

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---